Stock Earnings

Question 1

What are Apellis Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Apellis Pharmaceuticals Inc has a total asset of $885, Net loss of $-197

Question 2

What are the key financial ratios for APLS?

Accepted Answer

Apellis Pharmaceuticals Inc's Current ratio is 1.34, has a Net margin is -25.22, sales per share of $6.3.

Question 3

How is Apellis Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Apellis Pharmaceuticals Inc data is not available.

Question 4

Is Apellis Pharmaceuticals Inc profitable?

Accepted Answer

no, according to the latest financial statements, Apellis Pharmaceuticals Inc has a net loss of $-197

Question 5

Does Apellis Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Apellis Pharmaceuticals Inc has liability of 656

Question 6

How many outstanding shares for Apellis Pharmaceuticals Inc?

Accepted Answer

Apellis Pharmaceuticals Inc has a total outstanding shares of 124.49

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,016	781	396	75	66	250
Revenue Growth (YoY)	42%	97%	428%	14%	-74%	--
Cost of Revenue	113	117	58	5	5	25
Gross Profit	903	663	338	69	61	225
Selling, General & Admin	524	501	500	277	176	139
Research & Development	297	327	354	387	420	299
Operating Expenses	822	828	855	664	597	439
Other Non Operating Income (Expenses)	-1	-2	0	0	1	0
Pretax Income	46	-196	-526	-651	-746	-343
Income Tax Expense	1	1	2	0	0	1
Net Income	44	-197	-528	-652	-746	-344
Net Income Growth	-118%	-63%	-19%	-13%	117%	13%
Shares Outstanding (Diluted)	130.06	123.9	118.67	106.1	84.4	75.2
Shares Change (YoY)	5%	4%	12%	26%	12%	21%
EPS (Diluted)	0.34	-1.59	-4.45	-6.15	-8.84	-4.59
EPS Growth	-117%	-64%	-28%	-30%	93%	-6%
Free Cash Flow	78	-88	-595	-515	-564	-165
Free Cash Flow Per Share	0.59	-0.71	-5.01	-4.85	-6.68	-2.19
Gross Margin	88.87%	84.89%	85.35%	92%	92.42%	90%
Operating Margin	7.87%	-20.99%	-130.55%	-792%	-812.12%	-85.2%
Profit Margin	4.33%	-25.22%	-133.33%	-869.33%	-1,130.3%	-137.6%
Free Cash Flow Margin	7.67%	-11.26%	-150.25%	-686.66%	-854.54%	-66%
EBITDA	81	-163	-516	-593	-535	-213
EBITDA Margin	7.97%	-20.87%	-130.3%	-790.66%	-810.6%	-85.2%
D&A For EBITDA	1	1	1	1	1	0
EBIT	80	-164	-517	-594	-536	-213
EBIT Margin	7.87%	-20.99%	-130.55%	-792%	-812.12%	-85.2%
Effective Tax Rate	2.17%	-0.51%	-0.38%	0%	0%	-0.29%

Apellis Pharmaceuticals Inc (APLS) Price